Literature DB >> 6134901

Rash, eosinophilia, and hyperkalaemia associated with enalapril.

J N Barnes, E S Davies, C B Gent.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6134901     DOI： 10.1016/s0140-6736(83)90020-x

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

1.  Severe cutaneous reactions to captopril and enalapril; histological study and comparison with early mycosis fungoides.

Authors:  P N Furness; M J Goodfield; K A MacLennan; A Stevens; L G Millard
Journal:  J Clin Pathol       Date:  1986-08       Impact factor: 3.411

Review 2.  Enalapril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure.

Authors:  P A Todd; R C Heel
Journal:  Drugs       Date:  1986-03       Impact factor: 9.546

Review 3.  Enalapril. An update of its pharmacological properties and therapeutic use in congestive heart failure.

Authors:  P A Todd; K L Goa
Journal:  Drugs       Date:  1989-02       Impact factor: 9.546

4.  Tolerability of long term therapy with enalapril maleate in patients resistant to other therapies and intolerant to captopril.

Authors:  E J Rucinska; R Small; W S Mulcahy; D L Snyder; P V Rodel; J E Rush; R D Smith; J F Walker; J D Irvin
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Mar-Apr

Review 5.  Enalapril. A reappraisal of its pharmacology and therapeutic use in hypertension.

Authors:  P A Todd; K L Goa
Journal:  Drugs       Date:  1992-03       Impact factor: 9.546
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.